Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Clinical trial NCT07485569 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07485569
Sponsor: Radboud University Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Thyroid Cancer Stage IV Anaplastic Thyroid Cancer Differentiated Thyroid Cancer Poorly Differentiated Thyroid Carcinoma

Start date: 2026-06-01
Primary completion: 2027-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.